FDA-approved gene therapy invented at Nationwide Children's carries a $3.2M price tag. Here's why.
On Wednesday, a 5-year-old boy in Washington, D.C., received the first infusion with FDA-approved Elevidys, a gene therapy invented at Nationwide Children's Hospital for Duchenne muscular dystrophy, which usually kills by age 30.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Carrie Ghose Source Type: news
More News: Children | Gene Therapy | Genetics | Health Management | Hospitals | Muscular Dystrophy | Pharmaceuticals | Reflex Sympathetic Dystrophy